Last Updated: September 28, 2026

Hetero Labs Ltd V Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD V

HETERO LABS LTD V has eighty-four approved drugs.

There are two tentative approvals on HETERO LABS LTD V drugs.

Summary for Hetero Labs Ltd V

US Patents:	0
Tradenames:	79
Ingredients:	78
NDAs:	84

Drugs and US Patents for Hetero Labs Ltd V

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hetero Labs Ltd V	QUETIAPINE FUMARATE	quetiapine fumarate	TABLET;ORAL	204316-001	Jun 16, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd V	VALACYCLOVIR HYDROCHLORIDE	valacyclovir hydrochloride	TABLET;ORAL	203047-001	Apr 8, 2015	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd V	ENTECAVIR	entecavir	TABLET;ORAL	205740-001	Aug 21, 2015	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd V	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; losartan potassium	TABLET;ORAL	219869-001	May 27, 2026	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd V	TEMOZOLOMIDE	temozolomide	CAPSULE;ORAL	210030-005	Aug 23, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd V	LAMIVUDINE	lamivudine	TABLET;ORAL	203277-001	Jan 6, 2014	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd V	SILDENAFIL CITRATE	sildenafil citrate	FOR SUSPENSION;ORAL	213014-001	May 11, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.